AbbVie | ABBV - Assets

Abbvie reported $141.33B in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Assets Change
ALKERMES ALKS:US USD 1.96B 22.08M
Amgen AMGN:US USD 65.12B 1.42B
Astrazeneca AZN:US USD 96.48B 2.3B
AstraZeneca AZN:LN USD 96.48B 2.3B
Biogen BIIB:US USD 24.55B 300.1M
Biomarin Pharmaceutical BMRN:US USD 6.38B 111.03M
Coherus Biosciences CHRS:US USD 480.85M 70.06M
Eisai 4523:JP JPY 1.25T 10.21B
Endo International Ordinary Shares ENDP:US USD 6.01B 355.8M
Gilead Sciences GILD:US USD 63.17B 614M
GlaxoSmithKline GSK:LN GBP 60.15B 167M
Horizon Pharma HZNP:US USD 9.11B 86.75M
Infinity Pharmaceuticals INFI:US USD 51.59M 10.27M
Intercept Pharmaceuticals ICPT:US USD 553.71M 5.69M
JAZZ PHA JAZZ:US USD 10.84B 450.59M
Medtronic MDT:US USD 94.13B 893M
Neurocrine Biosciences NBIX:US USD 2.37B 225.3M
Novartis NOVN:VX USD 117.45B 1.01B
Pacira Pharmaceuticals PCRX:US USD 1.68B 53.16M
Perrigo Ordinary Shares PRGO:US USD 11.02B 339.8M
Regeneron Pharmaceuticals REGN:US USD 29.21B 1.54B
Revance Therapeutics RVNC:US USD 581.9M 129.69M
Roche Holding ROG:VX 88.15B 1.42B
Teva Pharmaceutical Industries TEVA:US USD 44.01B 246M
Ultragenyx Pharmaceutical RARE:US USD 1.55B 73.03M
United Therapeutics UTHR:US USD 6.04B 262.9M
Vertex Pharmaceuticals VRTX:US USD 18.15B 1.44B
Zoetis ZTS:US USD 14.92B 1.25B